PRESS RELEASE published on 02/22/2023 at 18:05, 1 year 8 months ago Abivax annonce le succès d’un financement cross-over sursouscrit de 130 millions d’euros au prix du marché, par des investisseurs américains et européens de premier plan
PRESS RELEASE published on 02/17/2023 at 08:00, 1 year 8 months ago Abivax appoints Dr. Sheldon Sloan, M.D., as Chief Medical Officer
PRESS RELEASE published on 02/17/2023 at 08:00, 1 year 8 months ago Abivax: Le Dr. Sheldon Sloan, M.D., est nommé Directeur Médical d’Abivax
PRESS RELEASE published on 02/14/2023 at 18:00, 1 year 8 months ago Abivax to present blood and rectal tissue data from UC patients treated with obefazimod at the 18th Congress of ECCO
PRESS RELEASE published on 02/14/2023 at 18:00, 1 year 8 months ago Abivax présentera lors du 18ème Congrès de l’ECCO des données issues d’échantillons sanguins et de biopsies rectales de patients atteints de RCH et traités avec obefazimod
PRESS RELEASE published on 01/31/2023 at 18:00, 1 year 9 months ago ABIVAX: NOTICE TO HOLDERS OF BONDS CONVERTIBLE AND/OR EXCHANGEABLE INTO NEW AND/OR EXISTING SHARES (OCEANES) WITH A NOMINAL VALUE OF EUR 24,999,975.99
PRESS RELEASE published on 01/31/2023 at 18:00, 1 year 9 months ago ABIVAX: AVIS AUX PORTEURS D’OBLIGATIONS CONVERTIBLES/ECHANGEABLES EN ACTIONS NOUVELLES ET/OU EXISTANTES (OCEANES) D’UN MONTANT NOMINAL DE 24 999 975,99 EUROS
PRESS RELEASE published on 01/30/2023 at 18:00, 1 year 9 months ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote
PRESS RELEASE published on 01/30/2023 at 18:00, 1 year 9 months ago ABIVAX: Bilan semestriel du contrat de liquidité au 31 décembre 2022
PRESS RELEASE published on 01/05/2023 at 08:00, 1 year 10 months ago Abivax publishes novel data with respect to obefazimod’s anti-inflammatory mechanism of action
Published on 11/08/2024 at 19:00, 1 hour 10 minutes ago Clear Start Tax: The Trusted Leader for Navigating Complex IRS Programs, Helping Taxpayers Nationwide
Published on 11/08/2024 at 18:15, 1 hour 55 minutes ago AccreditedEvents.com Presents High Performance Battery (HPB) for Filming on New to The Street at NYSE, Followed by Investor Event at Hudson Yards, NYC, on 11/11
Published on 11/08/2024 at 18:05, 2 hours 5 minutes ago Polaris Renewable Energy Announces Corporate and Bond Instrument Credit Rating
Published on 11/08/2024 at 17:31, 2 hours 39 minutes ago Alphinat Announces a Profit of $803 for Quarter Ended February 29, 2024
Published on 11/08/2024 at 16:00, 4 hours 10 minutes ago MANAMAURI, the High-Quality Energy Drink Brand, Joins EastBridge Global Investments for Major International Expansion
Published on 11/08/2024 at 18:35, 1 hour 35 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/08/2024 at 18:20, 1 hour 50 minutes ago ENCAVIS achieves results in the first three quarters of 2024 below the figures for the same period of the previous year due to unforeseeable events and adjusts guidance for the current financial year
Published on 11/08/2024 at 18:02, 2 hours 7 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/08/2024 at 18:00, 2 hours 10 minutes ago Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Published on 11/08/2024 at 18:00, 2 hours 10 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 11/08/2024 at 17:52, 2 hours 18 minutes ago Total number of voting rights and shares making up the share capital at October 31, 2024
Published on 11/08/2024 at 17:52, 2 hours 18 minutes ago Capital et droits de vote au 31 octobre 2024
Published on 11/08/2024 at 17:45, 2 hours 25 minutes ago CHARGEURS - Voting rights monthly statement as of October 31st, 2024
